I completed my medical degree at the University of Cape Town, graduating with distinction in clinical sciences in 2017. Currently a PhD candidate, my research focuses on innovative approaches to tuberculosis diagnostics. I am particularly interested in advancing and integrating novel technologies to improve health system responses. This is a placeholder text for saving purposes.
The PATHFAST TB LAM Ag assay provides a promising alternative to MGIT culture. The relatively good diagnostic performance in minimally symptomatic and subclinical TB cases highlights its potential as a tool in TB control, treatment evaluation and research in general.
Source: Conference 2024Community-based active case-finding using a point-of-care (POC) molecular tool is feasible in resource-limited settings. This strategy improves treatment initiation compared to centralised laboratory-based testing. These findings show that POC diagnosis is critical for an effective ACF strategy.
Source: Conference 2024Point-of-care diagnostics significantly accelerate tuberculosis treatment initiation compared to testing performed at a centralised facility, thereby reducing periods of transmissibility. These data support the integration of point-of-care diagnostics in community-based active case-finding strategies.
Source: Conference 2024